Evaluation of the efficacy of naratriptan for the treatment and prevention of post traumatic headache associated with cognitive dysfunction.
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Naratriptan (Primary)
- Indications Headache
- Focus Therapeutic Use
- 09 Feb 2010 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 09 Feb 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Sep 2009 Planned end date changed from 1 Nov 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.